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A quantitative autoradiographic assay for a novel L-[3H]glutamate binding site in rodent brain has been 
developed. Binding to this site was distinguished by its high affinity for quisqualate (QA), ibotenate, gluta- 
mate and trans-l-amino-cyclopentyl-l,3-dicarboxylic acid (trans-ACPD), but low affinity for [RS]-~- 
amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), kainate and N-methyl-o-aspartate 
(NMDA). 'AMPA-insensitive, QA-sensitive [3H]glutamate binding' (AiQsGB) had a heterogeneous distri- 
bution in rat brain with high levels observed in molecular layer of cerebellum, striatum, and lateral septum. 
AiQsGB was reduced in molecular layer of cerebellum in mice lacking Purkinje cells. AiQsGB appears 
to represent binding to the 'metabotropic' neuronal excitatory amino acid receptor linked to phospho- 
inositide metabolism. 
Excitatory amino acids (EAA) are believed to be the predominant e x c i t a t ~  neu- 
rotransmitters within the mammalian central nervous system [3,10]. EAA exert their 
effects via multiple receptors. At least two of these receptors, the NMDA receptor 
and the AMPA/quisqualate/kainate receptor are linked to ion channels. Selective 
antagonists for the AMPA/quisqualate/kainate receptor have been identified [4]. 
Recently, the existence of another EAA receptor has been proposed which, in con- 
trast to the ion channel-linked, or 'ionotropic' EAA receptors, is a 'metabotropic' 
receptor linked to phosphoinositide metabolism [11, 18, 19]. This receptor appears 
to play an important role in development and response to injury. The lack of specific 
antagonists and binding assays for this receptor, however, has hindered our ability 
to define its role in normal brain function. This metabotropic receptor is stimulated 
by quisqualate, L-glutamate and ibotenate and is insensitive to AMPA, NMDA and 
kainate [11-13, 16-18]. We have characterized L-[3H]glutamate binding that likely 
represents binding to the putative metabotropic receptor. 
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TABLE I 
THE PHARMACOLOGY OF [3H]AMPA BINDING AND AMPA-INSENSITIVE, QUISQUALATE- 
SENSITIVE [3H] GLUTAMATE BINDING IN CEREBELLAR MOLECULAR LAYER 
Values represent the mean of at least 3 experiments each carried out in triplicate. 
IC50 ~M 4- s.e.m.) 
Competitor [3H]AMPA binding* [3H]Glutamate binding 
Quisqualate 0.0814- o.015 0.052 4- 0.025 
Glutamate 1.78 +0.49 0.181 4-0.058 
AMPA 0.252 4- 0.024 > 100 
Ibotenate > 100 3.15 4- 0.77 
trans-ACPD > 100 10.74- 1.9 
CNQX 0.3584-0.031 > 100 
DNQX 0.3394-0.011 > 100 
APB > 100 > 100 
GDEE > 100 > 100 
7DGG > 100 > 100 
Kynurenate > 100 > 100 
Cystine n.d.** > 100 
SITS n.d. > 100 
*[3H]AMPA binding (37 nM, spec. act. 28 Ci/mmol) was carried out in 50 mM Tris-HCl buffer with 2.5 
mM CaCI2 and 100 mM potassium thiocyanate as previously described [15]. Non-specific binding was 
determined in the presence of 1 mM glutamate. AMPA-insensitive, quisqualate-sensitive [3H]glutamate 
binding (82 nM) was carried out in 50 mM Tris-HCl buffer, pH 7.2, with 2.5 mM CaCI2, 100 mM thio- 
cyanate, 10/xM AMPA and 100/tM NMDA. Nonspecific binding was determined in the presence of 2.5 
/tM quisqualate. 
**n.d. signifies 'not determined'. 
L-[3H]Glutamate  b inds  to the N M D A  and  A M P A  receptors  and  to a p o p u l a t i o n  
o f  sites tha t  a re  sensit ive to qu isqua la te  but  no t  A M P A  [2, 14]. In  these exper iments ,  
20 a m  sect ions o f  roden t  b ra in  were r insed for  30 min in 50 m M  Tris-HC1 buffer 
with 2.5 m M  CaCI2, p H  7.2, and  then dried.  Sect ions were incuba ted  for  45 min  in 
L-Jai l ]glutamate  (82-200 nM,  spec. act.  28--46 Ci /mmol ,  A m e r s h a m )  in the above  
buffer with 100 m M  po ta s s ium th iocyana te  in the  presence or  absence  o f  var ious  
compounds .  Af t e r  incuba t ion ,  sect ions were r insed 3 t imes with  cold  buffer and  once 
with cold  2.5~b (v/v) g lu t a ra ldehyde  in ace tone  a n d  rap id ly  dr ied  unde r  a s t ream o f  
wa rm a i r  ( to ta l  r inse t ime was less than  10 see). Sect ions were p laced  in X- ray  cas- 
settes, a p p o s e d  to  t r i t ium-sensi t ive  film (Hyperf i lm,  A m e r s h a m  Corpo ra t i on ) ,  
exposed  for  two weeks a t  4°C and  deve loped  in D-19 ( K o d a k ) .  A u t o r a d i o g r a p h i c  
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images were analyzed by computer-based densitometry (Imaging Research, Inc., St. 
Catherine's, Ontario, Canada) [2]. 
In autoradiographic L-[3H]glutamate binding studies, calcium and chloride specifi- 
cally stimulate quisqualate-sensitive ~-[3H]glutamate binding. Unlike the chloride 
and calcium stimulated L-[3H]glutamate 'binding' or sequestration observed in fresh 
neuronal and astrocytic membrane preparations, however, this quisqualate-sensitive 
L-[3H]glutamate binding was insensitive to cystine, the anion channel blocker 4-aceta- 
mido-4'-isothiocyano-stilbene-2,2'-disulfonic acid (SITS), and L-2-amino-4-phos- 
phonobutyrate (L-APB) [2](Table I). Furthermore, two components of this quisqua- 
late-sensitive L-[3H]glutamate binding could be defined, AMPA-sensitive and 
AMPA-insensitive binding. The AMPA-sensitive, quisqualate-sensitive L-[3H]gluta - 
mate binding had the properties of the ionotropic AMPA receptor, i.e., it had an 
almost identical regional distribution to that of [3H]AMPA binding and inhibition 
by AMPA, quisqualate, and glutamate but not by ibotenate [2, 14]. AMPA's ability 
to displace L-[3H]glutamate binding was enhanced by thiocyanate, which stimulates 
[3H]AMPA binding [5, 14]. Nevertheless, a considerable component of quisqualate- 
sensitive L-[3H]glutamate binding remained in 50 mM Tris-chloride plus 2.5 mM 
CaC12, 100 mM thiocyanate, 100/tM NMDA and 10/~M AMPA (nonspecific bind- 
ing was defined as that binding remaining in the presence of 2.5/~M quisqualate). 
We studied the properties of this AMPA-insensitive, quisqualate-sensitive glutamate 
binding (AiQsGB). 
The pharmacology of AiQsGB was different from that of AMPA-sensitive L- 
[3H]glutamate binding or [3H]AMPA binding to the presumed ionotropic receptor 
(Table I). AiQsGB was greatest at 4°C and was reduced at 23°C and 37°C. The anion 
channel blocker, SITS (100/~M), displaced only 30% of binding and cystine (100/iM), 
which potently inhibits chloride dependent glutamate sequestration, blocked less 
than 25% of binding [8, 10]. Quisqualate was the most potent displacer of AiQsGB, 
followed by glutamate, ibotenate and trans-ACPD. The latter two drugs had no ef- 
fect on [3H]AMPA binding. L-APB, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), 
6,7-dinitroquinoxaline-2,3-dione (DNQX), kainate, L-aspartate, glutamyl-diethyl 
ester (GDEE), ~-D-glutamylglycine (~-DGG) and kynurenate were all ineffective dis- 
placers (ICs0s > 100/iM) of binding. The effective displacers of AiQsGB, quisqualate, 
glutamate, trans-ACPD and ibotenate, have all been shown to increase inositol phos- 
pholipid metabolism in tissue slices, neuronal cultures and/or synaptoneurosomes [6, 
7,11-13, 16-19]. The present ICs0 values for these compounds are lower than pre- 
viously reported ECs0 values for stimulation of inositol phospholipid metabolism. 
This difference may be due to a number of factors, including the temperature of the 
assay and the removal of inactivation systems for glutamate. In other neurotransmit- 
ter agonist binding studies, binding constants are frequently one to two orders of 
magnitude lower than the ECs0 for stimulation of a physiological response, e.g. 
acetylcholine, GABA and dopamine. Thus, the pharmacology of this binding site 
was consistent with that of the metabotropic receptor and distinct from that of the 
AMPA-sensitive ionotropic receptor [2, 10, 14, 17, 18]. 
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Fig. I. Regional distribution of AMPA-insensitive, quisqualate-sensitive [all]glutamate binding in rat 
brain (A) and cerebellar levels of AiQsGB in nervous mutant mice (B). Sections were incubated in [3H]glu- 
tamate (82 riM) in Tris-HC1 plus 2.5 mM CaC2, 100 mM thiocyanate, 10 gM AMPA and 100 gM NMDA. 
Adjacent sections were incubated as above with the addition of 2.5 gM quisqualate. Bars represent pmol 
of [3H]glutamate displaced by 2.5 gM quisqualate. Binding in the cerebellar molecular layer of nervous 
mutant homozygotes (nr/nr) was significantly decreased compared to their heterozygous littermates (+/nr) 
(°P < 0.0006), whereas AiQsGB levels were not significantly different in the granule cell layer. Abbrevia- 
tions: InfColl, inferior colliculus; LatSep, lateral septum; FrParCtx, fronto-parietal cortex; CingCtx, 
cingulate cortex; EntCtx, entorhinal cortex; SMDG, stratum moleculare of dentate gyrus; SRoCA3, stra- 
tum radiatum of CA3; SP-CA3, stratum pyramidale of CA3; SO-CA3, stratum oriens of CA3; Thal, thala- 
mus; CerGrn, cerebellar granule cell layer; CerMol, cerebellar molecular layer. Numbers after cortex labels 
refer to cortical layers. 
[2, 10, 14] (Fig. 1A). Binding was highest in lateral septum and cerebellar molecular 
layer. Binding was also dense in striatum, cingulate and entorhinal cortices and lower 
in hippocampus. Thalamus, brainstem and frontal-parietal cortex had low binding 
densities. 
In cerebellar Purkinje neurons, quisqualate produces longer lasting responses than 
other EAA's and these responses persist after diffusion of the quisqualate, suggesting 
the activation of a second messenger system [6]. In rat cerebellar slices, quisqualate 
and glutamate but not AMPA stimulate inositol phosphate turnover, whereas in cer- 
ebellar slices from mutant mice lacking Purkinje cells, glutamate stimulation of phos- 
phoinositide turnover is abolished [1]. We examined the neuronal localization of 
AiQsGB in mouse cerebellum (Fig. 1B). In nervous mutant mice (which lack Purkinje 
cells), AiQsGB was markedly reduced in the cerebellar molecular layer, the area in 
which Purkinje cell dendrites are found, compared to binding in heterozygous litter- 
mate controls (Fig. 1B). [3H]AMPA binding and total quisqualate-sensitive [3H]gluta- 
mate binding also were very reduced in nervous mutants [9, 15]. Thus, both ionotropic 
and metabotropic quisqualate receptors appear to be concentrated on Purkinje cells. 
The ionotropic receptor is the likely mediator of fast synaptic transmission at the par- 
allel fiber Purkinje cell synapses whereas the metabotropic receptor probably plays 
a role in the generation of the longer lasting quisqualate responses and long-term de- 
pression observed in cerebellum [6, 7]. The evidence from mutant mouse cerebella 
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s t rongly  suggests tha t  A i Q s G B  is local ized on pos t synap t i c  neurona l  e lements  ra ther  
than  on p resynap t i c  or  glial sites. 
The present  s tudy suggests  tha t  A i Q s G B  represents  L-[3H]glutamate b ind ing  to the 
m e t a b o t r o p i c  E A A  receptor .  A i Q s G B  is dis t inct  f rom [3H]AMPA binding,  is differ- 
ent ia l ly  d i s t r ibu ted  t h r o u g h o u t  the ra t  bra in ,  and  is l ikely local ized to pos t synap t i c  
elements.  The deve lopmen t  o f  a b ind ing  assay for  this  r ecep to r  site should  al low its 
eva lua t ion  in h u m a n  hypoxic- i schemic  a n d  neurodegenera t ive  b ra in  p a t h o l o g y  and 
faci l i tate  the ident i f ica t ion o f  m o r e  selective and  po ten t  agonis t s  and  antagonis ts .  
This  work  was s u p p o r t e d  by  G r a n t  N R S A  5T32 GM07863  f rom the N a t i o n a l  In- 
s t i tutes o f  Hea l t h  and G r a n t  NS 19613 f rom the U.S.  Publ ic  Hea l th  Service. 
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